MedPath

THE EYE INSTITUTE OF WEST FLORIDA

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

1

Active:0
Completed:1

Trial Phases

1 Phases

Phase 4:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials

Phase 4
1 (100.0%)

"A Prospective Study of the Efficacy of Intracameral Dexamethasone (Dexycu™) Compared to Standard of Care Treatment for Post-Cataract Surgical Pain and Anterior Chamber Inflammation"

Phase 4
Completed
Conditions
Cataract
Interventions
Drug: Standard of Care post operative eye drops (steroid, antibiotic, NSAID)
Drug: Dexycu
First Posted Date
2021-03-04
Last Posted Date
2025-02-25
Lead Sponsor
The Eye Institute of West Florida
Target Recruit Count
25
Registration Number
NCT04781335
Locations
🇺🇸

The Eye Institute of West Florida, Largo, Florida, United States

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.